Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

98.83 +9.56 (+10.71%)
Official Closing Price Updated: 4:10 PM EDT, Jul 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
56 57 Next >
News headline image
Abbott Laboratories (ABT) Q3 Earnings Report Preview: What To Look For
Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
 
Via Benzinga
News headline image
Dow Jones Soars on Trump's Tariff Remarks, Signaling Market Volatility Amidst Trade Policy Shifts
New York, NY – October 13, 2025 – The Dow Jones Industrial Average has experienced significant upward momentum in recent months, notably jumping by hundreds of points on multiple occasions in early... 
Via MarketMinute
Topics Economy Government Stocks
News headline image
Retail Investors' Top Stocks With Earnings This Week: Fastenal, ASML, TSMC And More ↗
Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this week. 
Via Benzinga
News headline image
A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Forecasting The Future: 12 Analyst Projections For Abbott Laboratories ↗
 
Via Benzinga
News headline image
3 Dividend Stocks to Double Up On Right Now ↗
The time is right for buying more of these great dividend stocks. 
Via The Motley Fool
Topics Economy Energy
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test
In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
2 Profitable Stocks to Consider Right Now and 1 We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now ↗
This fund makes it easy to invest in the top dividend stocks. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market
Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Investing Screen ↗
Discover Abbott Laboratories (ABT), a top Caviar Cruise screen pick. This healthcare leader excels in profitability, financial health, and cash flow, making it a strong long-term quality investment. 
Via Chartmill
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Avoid
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Retirement
News headline image
Abbott Laboratories (NYSE:ABT) Presents a Technical Breakout Setup for Investors ↗
Abbott Laboratories (ABT) is a technical breakout candidate, showing a strong uptrend and a perfect consolidation setup, suggesting a potential upward move. 
Via Chartmill
News headline image
The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗
The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes. 
Via Benzinga
News headline image
Don't Overlook These 2 Dividend Kings in Today's Volatile Market ↗
These businesses may be "boring," but that's a good thing in today's market. 
Via The Motley Fool
Topics Economy Government World Trade
News headline image
8 Dividend Growth Stocks Every Investor Should Consider ↗
These dividend powerhouses compound wealth through decades of consecutive increases and sustainable payout ratios. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Navigating the Emotional Tides: Investor Psychology in a Volatile Market
The financial markets are currently a tempestuous sea, marked by a perplexing interplay of underlying strength and overt volatility, largely driven by the powerful forces of investor psychology. As of... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA ↗
Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott's Libre 3. 
Via Benzinga
News headline image
September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?
As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
3 No-Brainer Dividend Stocks to Buy in September ↗
The attraction of these dividend stocks isn't limited to their dividends. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock ↗
 
Via Benzinga
News headline image
3 S&P 500 Stocks to Keep an Eye On
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
1 Reason Every Investor Should Know About AbbVie (ABBV) ↗
This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Dividend Stocks to Double Up on Right Now ↗
Investors can feel good about upping their bets on these great dividend stocks. 
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years? ↗
There is more to like than the dividend with these companies. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Peering Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.